In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin.

Objectives: This study aimed to investigate in-hospital mortality rates in patients with coronavirus disease (COVID-19) according to enoxaparin and heparin use.

Methods: This retrospective cohort study included 962 patients admitted to two hospitals in Kuwait with a confirmed diagnosis of COVID-19. Cumulative all-cause mortality rate was the primary outcome.

In-hospital mortality in SARS-CoV-2 stratified by the use of corticosteroid.

Objective: To investigate COVID-19 related mоrtаlity according to the use of corticosteroid therapy.

Design: Retrospective cohort study.

Setting: Two tertiary hospitals in Kuwait.

In-hospital mortality in SARS-CoV-2 stratified by gamma-glutamyl transferase levels.

Background: This study investigates in-hospital mortality amongst patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its relation to serum levels of gamma-glutamyl transferase (GGT).

Methods: Patients were stratified according to serum levels of gamma-glutamyl transferase (GGT) (GGT<50 IU/L or GGT≥50 IU/L).

Results: A total of 802 participants were considered, amongst whom 486 had GGT<50 IU/L and a mean age of 48.